Invention Grant
- Patent Title: Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof
-
Application No.: US17258273Application Date: 2019-07-05
-
Publication No.: US12128028B2Publication Date: 2024-10-29
- Inventor: Marc Rogers , Robert Kirby , Gakujun Shomi , Takuya Matsuo , Satoru Kobayashi , Junichiro Kanazawa , Nobutaka Yamaoka , Makoto Torizuka , Koichi Suzawa
- Applicant: METRION BIOSCIENCES LIMITED
- Applicant Address: GB Great Abingdon
- Assignee: METRION BIOSCIENCES LIMITED
- Current Assignee: METRION BIOSCIENCES LIMITED
- Current Assignee Address: GB Great Abingdon
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB 11165 2018.07.06
- International Application: PCT/GB2019/051903 2019.07.05
- International Announcement: WO2020/008206A 2020.01.09
- Date entered country: 2021-01-06
- Main IPC: A61K31/4164
- IPC: A61K31/4164 ; A61K31/4178 ; A61K31/439 ; A61K31/4439 ; A61K31/454 ; A61K31/46 ; A61K31/5377 ; A61K31/55 ; C07D233/28 ; C07D235/02 ; C07D401/06 ; C07D401/12 ; C07D403/06 ; C07D403/12 ; C07D405/12 ; C07D409/12 ; C07D471/08 ; C07D491/107
Abstract:
The invention relates to heterocyclic sulfonamide derivatives and their use in the treatment and prophylaxis of autoimmune, inflammatory, cardiovascular, neuronal, auditory, renal and metabolic mediated diseases, and to compositions containing said derivatives and processes for their preparation.
Public/Granted literature
- US20210275499A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF Public/Granted day:2021-09-09
Information query
